| Filed | As-Of/On | Form | Fullname | Symbol | Country | Industry | Shares | Activity | Shares Change | Shares Pct. Change | Hypothetical Old Value | Hypothetical New Value | Hypothetical Value Chg. | Hypothetical Return | Hypothetical Results |
Director |
Other |
Ten Pct |
Officer |
Officer Title |
History |
|---|
| 2009-07-31 | 2009-07-30 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 39,500 | Added More | 6,000 | 21.81 % | $1,932,735 | $1,856,895 | $-75,840 | -3.92 % | $-11,520 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2009-07-31 | 2009-07-30 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 48,500 | Added More | 9,000 | 29.50 % | $2,373,105 | $2,279,985 | $-93,120 | -3.92 % | $-17,280 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2009-07-31 | 2009-07-30 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 33,500 | Sold Some | -15,000 | -30.92 % | $1,639,155 | $1,574,835 | $-64,320 | -3.92 % | $28,800 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2009-06-26 | 2009-06-25 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 48,500 | Added More | 15,000 | 81.08 % | $2,304,720 | $2,279,985 | $-24,735 | -1.07 % | $-7,650 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2009-06-26 | 2009-06-25 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 33,500 | Sold Some | -15,000 | -30.92 % | $1,591,920 | $1,574,835 | $-17,085 | -1.07 % | $7,650 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2009-06-01 | 2009-05-28 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 33,500 | Sold Some | -15,000 | -30.92 % | $1,432,795 | $1,574,835 | $142,040 | 9.91 % | $-63,600 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2009-06-01 | 2009-05-28 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 48,500 | Added More | 15,000 | 81.08 % | $2,074,345 | $2,279,985 | $205,640 | 9.91 % | $63,600 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2009-05-01 | 2009-04-30 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 48,500 | Added More | 15,000 | 81.08 % | $2,173,285 | $2,279,985 | $106,700 | 4.90 % | $33,000 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2009-05-01 | 2009-04-30 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 33,500 | Sold Some | -15,000 | -30.92 % | $1,501,135 | $1,574,835 | $73,700 | 4.90 % | $-33,000 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2009-03-30 | 2009-03-26 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 33,500 | Sold Some | -15,000 | -30.92 % | $1,528,270 | $1,574,835 | $46,565 | 3.04 % | $-20,850 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2009-03-30 | 2009-03-26 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 48,500 | Added More | 15,000 | 81.08 % | $2,212,570 | $2,279,985 | $67,415 | 3.04 % | $20,850 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2009-03-02 | 2009-02-26 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 33,500 | Sold Some | -15,000 | -30.92 % | $1,483,045 | $1,574,835 | $91,790 | 6.18 % | $-41,100 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2009-03-02 | 2009-02-26 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 48,500 | Added More | 15,000 | 81.08 % | $2,147,095 | $2,279,985 | $132,890 | 6.18 % | $41,100 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2009-02-02 | 2009-01-29 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 33,500 | Sold Some | -15,000 | -30.92 % | $1,737,645 | $1,574,835 | $-162,810 | -9.36 % | $72,900 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2009-02-02 | 2009-01-29 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 48,500 | Added More | 15,000 | 81.08 % | $2,515,695 | $2,279,985 | $-235,710 | -9.36 % | $-72,900 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2008-11-14 | 2008-11-12 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 35,517 | Sold Some | -13,450 | -27.46 % | $1,666,458 | $1,669,654 | $3,197 | 0.19 % | $-1,211 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2008-11-14 | 2008-11-12 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 48,967 | Added More | 13,450 | 60.95 % | $2,297,532 | $2,301,939 | $4,407 | 0.19 % | $1,211 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2008-10-31 | 2008-10-30 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 35,517 | Sold Some | -12,000 | -25.25 % | $1,628,454 | $1,669,654 | $41,200 | 2.52 % | $-13,920 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2008-10-31 | 2008-10-30 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 47,517 | Added More | 24,000 | -4968.94 % | $2,178,654 | $2,233,774 | $55,120 | 2.52 % | $27,840 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2008-10-09 | 2008-10-08 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 23,517 | Sold Some | -13,450 | -36.38 % | $941,621 | $1,105,534 | $163,913 | 17.40 % | $-93,747 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2008-10-09 | 2008-10-08 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 36,967 | Added More | 13,450 | 133.60 % | $1,480,159 | $1,737,819 | $257,660 | 17.40 % | $93,747 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2008-09-11 | 2008-09-10 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 23,517 | Sold Some | -13,450 | -36.38 % | $1,153,274 | $1,105,534 | $-47,740 | -4.13 % | $27,304 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2008-09-11 | 2008-09-10 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 36,967 | Added More | 13,450 | 133.60 % | $1,812,862 | $1,737,819 | $-75,043 | -4.13 % | $-27,304 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2008-08-14 | 2008-08-13 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 23,517 | Sold Some | -13,450 | -36.38 % | $1,333,179 | $1,105,534 | $-227,645 | -17.07 % | $130,196 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2008-08-14 | 2008-08-13 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 36,967 | Added More | 13,450 | 133.60 % | $2,095,659 | $1,737,819 | $-357,841 | -17.07 % | $-130,196 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2008-07-10 | 2008-07-09 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 36,967 | Added More | 13,450 | 133.60 % | $2,018,029 | $1,737,819 | $-280,210 | -13.88 % | $-101,951 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2008-07-10 | 2008-07-09 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 23,517 | Sold Some | -13,450 | -36.38 % | $1,283,793 | $1,105,534 | $-178,259 | -13.88 % | $101,951 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2008-06-12 | 2008-06-11 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 36,967 | Added More | 13,450 | 133.60 % | $1,949,270 | $1,737,819 | $-211,451 | -10.84 % | $-76,934 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2008-06-12 | 2008-06-11 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 23,517 | Sold Some | -13,450 | -36.38 % | $1,240,051 | $1,105,534 | $-134,517 | -10.84 % | $76,934 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2008-05-16 | 2008-05-14 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 24,551 | Sold Some | -100 | -0.40 % | $1,303,413 | $1,154,143 | $-149,270 | -11.45 % | $608 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2008-05-16 | 2008-05-14 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 23,517 | Sold Some | -200 | -0.84 % | $1,248,518 | $1,105,534 | $-142,983 | -11.45 % | $1,216 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2008-05-16 | 2008-05-14 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 23,717 | Sold Some | -834 | -3.39 % | $1,259,136 | $1,114,936 | $-144,199 | -11.45 % | $5,071 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2008-05-16 | 2008-05-14 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 36,967 | Added More | 1,600 | 4.73 % | $1,962,578 | $1,737,819 | $-224,759 | -11.45 % | $-9,728 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2008-05-16 | 2008-05-14 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 36,767 | Sold Some | -200 | -0.54 % | $1,951,960 | $1,728,417 | $-223,543 | -11.45 % | $1,216 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2008-05-16 | 2008-05-14 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 36,267 | Sold Some | -500 | -1.35 % | $1,925,415 | $1,704,912 | $-220,503 | -11.45 % | $3,040 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2008-05-16 | 2008-05-14 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 35,767 | Sold Some | -500 | -1.37 % | $1,898,870 | $1,681,407 | $-217,463 | -11.45 % | $3,040 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2008-05-16 | 2008-05-14 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 35,467 | Sold Some | -300 | -0.83 % | $1,882,943 | $1,667,304 | $-215,639 | -11.45 % | $1,824 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2008-05-16 | 2008-05-14 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 35,367 | Added More | 11,850 | 101.56 % | $1,877,634 | $1,662,603 | $-215,031 | -11.45 % | $-72,048 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2008-05-16 | 2008-05-14 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 35,178 | Sold Some | -289 | -0.81 % | $1,867,600 | $1,653,718 | $-213,882 | -11.45 % | $1,757 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2008-05-16 | 2008-05-14 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 34,667 | Sold Some | -511 | -1.45 % | $1,840,471 | $1,629,696 | $-210,775 | -11.45 % | $3,107 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2008-05-16 | 2008-05-14 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 32,667 | Sold Some | -2,000 | -5.76 % | $1,734,291 | $1,535,676 | $-198,615 | -11.45 % | $12,160 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2008-05-16 | 2008-05-14 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 32,028 | Sold Some | -639 | -1.95 % | $1,700,367 | $1,505,636 | $-194,730 | -11.45 % | $3,885 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2008-05-16 | 2008-05-14 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 32,007 | Sold Some | -21 | -0.06 % | $1,699,252 | $1,504,649 | $-194,603 | -11.45 % | $128 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2008-05-16 | 2008-05-14 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 31,907 | Sold Some | -100 | -0.31 % | $1,693,943 | $1,499,948 | $-193,995 | -11.45 % | $608 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2008-05-16 | 2008-05-14 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 31,407 | Sold Some | -500 | -1.56 % | $1,667,398 | $1,476,443 | $-190,955 | -11.45 % | $3,040 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2008-05-16 | 2008-05-14 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 31,307 | Sold Some | -100 | -0.31 % | $1,662,089 | $1,471,742 | $-190,347 | -11.45 % | $608 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2008-05-16 | 2008-05-14 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 30,157 | Sold Some | -1,150 | -3.67 % | $1,601,035 | $1,417,681 | $-183,355 | -11.45 % | $6,992 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2008-05-16 | 2008-05-14 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 29,651 | Sold Some | -506 | -1.67 % | $1,574,172 | $1,393,894 | $-180,278 | -11.45 % | $3,076 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2008-05-16 | 2008-05-14 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 29,451 | Sold Some | -200 | -0.67 % | $1,563,554 | $1,384,492 | $-179,062 | -11.45 % | $1,216 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2008-05-16 | 2008-05-14 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 28,751 | Sold Some | -700 | -2.37 % | $1,526,391 | $1,351,585 | $-174,806 | -11.45 % | $4,256 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2008-05-16 | 2008-05-14 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 28,051 | Sold Some | -700 | -2.43 % | $1,489,228 | $1,318,678 | $-170,550 | -11.45 % | $4,256 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2008-05-16 | 2008-05-14 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 27,851 | Sold Some | -200 | -0.71 % | $1,478,610 | $1,309,276 | $-169,334 | -11.45 % | $1,216 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2008-05-16 | 2008-05-14 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 27,451 | Sold Some | -400 | -1.43 % | $1,457,374 | $1,290,472 | $-166,902 | -11.45 % | $2,432 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2008-05-16 | 2008-05-14 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 26,951 | Sold Some | -500 | -1.82 % | $1,430,829 | $1,266,967 | $-163,862 | -11.45 % | $3,040 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2008-05-16 | 2008-05-14 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 26,851 | Sold Some | -100 | -0.37 % | $1,425,520 | $1,262,266 | $-163,254 | -11.45 % | $608 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2008-05-16 | 2008-05-14 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 26,751 | Sold Some | -100 | -0.37 % | $1,420,211 | $1,257,565 | $-162,646 | -11.45 % | $608 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2008-05-16 | 2008-05-14 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 26,651 | Sold Some | -100 | -0.37 % | $1,414,902 | $1,252,864 | $-162,038 | -11.45 % | $608 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2008-05-16 | 2008-05-14 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 26,351 | Sold Some | -300 | -1.12 % | $1,398,975 | $1,238,761 | $-160,214 | -11.45 % | $1,824 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2008-05-16 | 2008-05-14 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 25,551 | Sold Some | -800 | -3.03 % | $1,356,503 | $1,201,153 | $-155,350 | -11.45 % | $4,864 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2008-05-16 | 2008-05-14 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 24,651 | Sold Some | -900 | -3.52 % | $1,308,722 | $1,158,844 | $-149,878 | -11.45 % | $5,472 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2008-04-11 | 2008-04-09 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 24,917 | Sold Some | -1,000 | -3.85 % | $1,261,797 | $1,171,348 | $-90,449 | -7.16 % | $3,630 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2008-04-11 | 2008-04-09 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 36,967 | Added More | 13,450 | 133.60 % | $1,872,009 | $1,737,819 | $-134,190 | -7.16 % | $-48,824 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2008-04-11 | 2008-04-09 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 34,567 | Sold Some | -2,400 | -6.49 % | $1,750,473 | $1,624,995 | $-125,478 | -7.16 % | $8,712 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2008-04-11 | 2008-04-09 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 33,852 | Sold Some | -715 | -2.06 % | $1,714,265 | $1,591,383 | $-122,883 | -7.16 % | $2,595 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2008-04-11 | 2008-04-09 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 33,652 | Sold Some | -200 | -0.59 % | $1,704,137 | $1,581,981 | $-122,157 | -7.16 % | $726 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2008-04-11 | 2008-04-09 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 33,052 | Sold Some | -600 | -1.78 % | $1,673,753 | $1,553,775 | $-119,979 | -7.16 % | $2,178 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2008-04-11 | 2008-04-09 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 32,352 | Sold Some | -700 | -2.11 % | $1,638,305 | $1,520,868 | $-117,438 | -7.16 % | $2,541 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2008-04-11 | 2008-04-09 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 31,367 | Sold Some | -985 | -3.04 % | $1,588,425 | $1,474,563 | $-113,862 | -7.16 % | $3,576 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2008-04-11 | 2008-04-09 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 30,592 | Sold Some | -775 | -2.47 % | $1,549,179 | $1,438,130 | $-111,049 | -7.16 % | $2,813 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2008-04-11 | 2008-04-09 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 29,892 | Sold Some | -700 | -2.28 % | $1,513,731 | $1,405,223 | $-108,508 | -7.16 % | $2,541 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2008-04-11 | 2008-04-09 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 29,492 | Sold Some | -400 | -1.33 % | $1,493,475 | $1,386,419 | $-107,056 | -7.16 % | $1,452 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2008-04-11 | 2008-04-09 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 27,967 | Sold Some | -1,525 | -5.17 % | $1,416,249 | $1,314,729 | $-101,520 | -7.16 % | $5,536 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2008-04-11 | 2008-04-09 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 27,317 | Sold Some | -650 | -2.32 % | $1,383,333 | $1,284,172 | $-99,161 | -7.16 % | $2,360 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2008-04-11 | 2008-04-09 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 26,317 | Sold Some | -1,000 | -3.66 % | $1,332,693 | $1,237,162 | $-95,531 | -7.16 % | $3,630 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2008-04-11 | 2008-04-09 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 25,917 | Sold Some | -400 | -1.51 % | $1,312,437 | $1,218,358 | $-94,079 | -7.16 % | $1,452 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2008-04-11 | 2008-04-09 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 23,917 | Sold Some | -1,000 | -4.01 % | $1,211,157 | $1,124,338 | $-86,819 | -7.16 % | $3,630 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2008-04-11 | 2008-04-09 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 23,517 | Sold Some | -400 | -1.67 % | $1,190,901 | $1,105,534 | $-85,367 | -7.16 % | $1,452 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2008-03-13 | 2008-03-12 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 21,500 | Sold Some | -100 | -0.46 % | $1,042,535 | $1,010,715 | $-31,820 | -3.05 % | $148 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2008-03-13 | 2008-03-12 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 34,950 | Added More | 13,450 | 167.08 % | $1,694,726 | $1,643,000 | $-51,726 | -3.05 % | $-19,906 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2008-03-13 | 2008-03-12 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 34,550 | Sold Some | -400 | -1.14 % | $1,675,330 | $1,624,196 | $-51,134 | -3.05 % | $592 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2008-03-13 | 2008-03-12 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 34,050 | Sold Some | -500 | -1.44 % | $1,651,085 | $1,600,691 | $-50,394 | -3.05 % | $740 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2008-03-13 | 2008-03-12 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 33,150 | Sold Some | -900 | -2.64 % | $1,607,444 | $1,558,382 | $-49,062 | -3.05 % | $1,332 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2008-03-13 | 2008-03-12 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 33,050 | Sold Some | -100 | -0.30 % | $1,602,595 | $1,553,681 | $-48,914 | -3.05 % | $148 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2008-03-13 | 2008-03-12 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 32,183 | Sold Some | -867 | -2.62 % | $1,560,554 | $1,512,923 | $-47,631 | -3.05 % | $1,283 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2008-03-13 | 2008-03-12 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 31,350 | Sold Some | -833 | -2.58 % | $1,520,162 | $1,473,764 | $-46,398 | -3.05 % | $1,233 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2008-03-13 | 2008-03-12 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 29,550 | Sold Some | -1,800 | -5.74 % | $1,432,880 | $1,389,146 | $-43,734 | -3.05 % | $2,664 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2008-03-13 | 2008-03-12 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 28,050 | Sold Some | -1,500 | -5.07 % | $1,360,145 | $1,318,631 | $-41,514 | -3.05 % | $2,220 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2008-03-13 | 2008-03-12 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 26,617 | Sold Some | -1,433 | -5.10 % | $1,290,658 | $1,251,265 | $-39,393 | -3.05 % | $2,121 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2008-03-13 | 2008-03-12 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 26,117 | Sold Some | -500 | -1.87 % | $1,266,413 | $1,227,760 | $-38,653 | -3.05 % | $740 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2008-03-13 | 2008-03-12 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 26,017 | Sold Some | -100 | -0.38 % | $1,261,564 | $1,223,059 | $-38,505 | -3.05 % | $148 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2008-03-13 | 2008-03-12 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 25,417 | Sold Some | -600 | -2.30 % | $1,232,470 | $1,194,853 | $-37,617 | -3.05 % | $888 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2008-03-13 | 2008-03-12 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 24,317 | Sold Some | -1,100 | -4.32 % | $1,179,131 | $1,143,142 | $-35,989 | -3.05 % | $1,628 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2008-03-13 | 2008-03-12 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 23,517 | Sold Some | -800 | -3.28 % | $1,140,339 | $1,105,534 | $-34,805 | -3.05 % | $1,184 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2008-03-13 | 2008-03-12 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 22,017 | Sold Some | -1,500 | -6.37 % | $1,067,604 | $1,035,019 | $-32,585 | -3.05 % | $2,220 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2008-03-13 | 2008-03-12 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 21,600 | Sold Some | -417 | -1.89 % | $1,047,384 | $1,015,416 | $-31,968 | -3.05 % | $617 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2008-02-15 | 2008-02-13 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 29,100 | Sold Some | -1,580 | -5.14 % | $1,298,442 | $1,367,991 | $69,549 | 5.35 % | $-3,776 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2008-02-15 | 2008-02-13 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 34,950 | Added More | 13,450 | 167.08 % | $1,559,469 | $1,643,000 | $83,531 | 5.35 % | $32,146 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2008-02-15 | 2008-02-13 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 34,800 | Sold Some | -150 | -0.42 % | $1,552,776 | $1,635,948 | $83,172 | 5.35 % | $-359 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2008-02-15 | 2008-02-13 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 34,700 | Sold Some | -100 | -0.28 % | $1,548,314 | $1,631,247 | $82,933 | 5.35 % | $-239 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2008-02-15 | 2008-02-13 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 34,500 | Sold Some | -200 | -0.57 % | $1,539,390 | $1,621,845 | $82,455 | 5.35 % | $-478 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2008-02-15 | 2008-02-13 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 33,500 | Sold Some | -1,000 | -2.89 % | $1,494,770 | $1,574,835 | $80,065 | 5.35 % | $-2,390 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2008-02-15 | 2008-02-13 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 32,600 | Sold Some | -900 | -2.68 % | $1,454,612 | $1,532,526 | $77,914 | 5.35 % | $-2,151 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2008-02-15 | 2008-02-13 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 31,900 | Sold Some | -700 | -2.14 % | $1,423,378 | $1,499,619 | $76,241 | 5.35 % | $-1,673 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2008-02-15 | 2008-02-13 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 30,780 | Sold Some | -1,120 | -3.51 % | $1,373,404 | $1,446,968 | $73,564 | 5.35 % | $-2,677 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2008-02-15 | 2008-02-13 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 30,680 | Sold Some | -100 | -0.32 % | $1,368,942 | $1,442,267 | $73,325 | 5.35 % | $-239 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2008-02-15 | 2008-02-13 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 28,253 | Sold Some | -847 | -2.91 % | $1,260,649 | $1,328,174 | $67,525 | 5.35 % | $-2,024 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2008-02-15 | 2008-02-13 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 27,853 | Sold Some | -400 | -1.41 % | $1,242,801 | $1,309,370 | $66,569 | 5.35 % | $-956 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2008-02-15 | 2008-02-13 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 27,800 | Sold Some | -53 | -0.19 % | $1,240,436 | $1,306,878 | $66,442 | 5.35 % | $-127 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2008-02-15 | 2008-02-13 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 27,000 | Sold Some | -800 | -2.87 % | $1,204,740 | $1,269,270 | $64,530 | 5.35 % | $-1,912 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2008-02-15 | 2008-02-13 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 25,800 | Sold Some | -1,200 | -4.44 % | $1,151,196 | $1,212,858 | $61,662 | 5.35 % | $-2,868 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2008-02-15 | 2008-02-13 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 25,400 | Sold Some | -400 | -1.55 % | $1,133,348 | $1,194,054 | $60,706 | 5.35 % | $-956 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2008-02-15 | 2008-02-13 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 25,200 | Sold Some | -200 | -0.78 % | $1,124,424 | $1,184,652 | $60,228 | 5.35 % | $-478 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2008-02-15 | 2008-02-13 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 24,000 | Sold Some | -1,200 | -4.76 % | $1,070,880 | $1,128,240 | $57,360 | 5.35 % | $-2,868 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2008-02-15 | 2008-02-13 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 23,700 | Sold Some | -300 | -1.25 % | $1,057,494 | $1,114,137 | $56,643 | 5.35 % | $-717 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2008-02-15 | 2008-02-13 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 22,400 | Sold Some | -1,300 | -5.48 % | $999,488 | $1,053,024 | $53,536 | 5.35 % | $-3,107 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2008-02-15 | 2008-02-13 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 21,500 | Sold Some | -900 | -4.01 % | $959,330 | $1,010,715 | $51,385 | 5.35 % | $-2,151 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2008-02-01 | 2008-01-31 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 31,500 | Added More | 10,000 | 86.95 % | $1,446,795 | $1,480,815 | $34,020 | 2.35 % | $10,800 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2008-02-01 | 2008-01-31 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 30,900 | Sold Some | -600 | -1.90 % | $1,419,237 | $1,452,609 | $33,372 | 2.35 % | $-648 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2008-02-01 | 2008-01-31 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 29,400 | Sold Some | -1,500 | -4.85 % | $1,350,342 | $1,382,094 | $31,752 | 2.35 % | $-1,620 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2008-02-01 | 2008-01-31 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 28,302 | Sold Some | -1,098 | -3.73 % | $1,299,911 | $1,330,477 | $30,566 | 2.35 % | $-1,186 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2008-02-01 | 2008-01-31 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 21,500 | Sold Some | -6,802 | -24.03 % | $987,495 | $1,010,715 | $23,220 | 2.35 % | $-7,346 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2008-01-10 | 2008-01-09 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 31,200 | Sold Some | -2,000 | -6.02 % | $1,504,464 | $1,466,712 | $-37,752 | -2.50 % | $2,420 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2008-01-10 | 2008-01-09 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 30,300 | Sold Some | -900 | -2.88 % | $1,461,066 | $1,424,403 | $-36,663 | -2.50 % | $1,089 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2008-01-10 | 2008-01-09 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 30,200 | Sold Some | -100 | -0.33 % | $1,456,244 | $1,419,702 | $-36,542 | -2.50 % | $121 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2008-01-10 | 2008-01-09 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 29,100 | Sold Some | -1,100 | -3.64 % | $1,403,202 | $1,367,991 | $-35,211 | -2.50 % | $1,331 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2008-01-10 | 2008-01-09 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 27,786 | Sold Some | -1,314 | -4.51 % | $1,339,841 | $1,306,220 | $-33,621 | -2.50 % | $1,590 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2008-01-10 | 2008-01-09 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 27,200 | Sold Some | -586 | -2.10 % | $1,311,584 | $1,278,672 | $-32,912 | -2.50 % | $709 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2008-01-10 | 2008-01-09 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 27,100 | Sold Some | -100 | -0.36 % | $1,306,762 | $1,273,971 | $-32,791 | -2.50 % | $121 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2008-01-10 | 2008-01-09 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 26,400 | Sold Some | -700 | -2.58 % | $1,273,008 | $1,241,064 | $-31,944 | -2.50 % | $847 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2008-01-10 | 2008-01-09 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 24,600 | Sold Some | -1,800 | -6.81 % | $1,186,212 | $1,156,446 | $-29,766 | -2.50 % | $2,178 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2008-01-10 | 2008-01-09 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 22,745 | Sold Some | -1,855 | -7.54 % | $1,096,764 | $1,069,242 | $-27,521 | -2.50 % | $2,245 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2008-01-10 | 2008-01-09 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 21,500 | Sold Some | -300 | -1.37 % | $1,036,730 | $1,010,715 | $-26,015 | -2.50 % | $363 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2008-01-10 | 2008-01-09 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 21,800 | Sold Some | -945 | -4.15 % | $1,051,196 | $1,024,818 | $-26,378 | -2.50 % | $1,143 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2008-01-10 | 2008-01-09 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 34,500 | Added More | 13,000 | 152.94 % | $1,663,590 | $1,621,845 | $-41,745 | -2.50 % | $-15,730 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2008-01-10 | 2008-01-09 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 34,400 | Sold Some | -100 | -0.28 % | $1,658,768 | $1,617,144 | $-41,624 | -2.50 % | $121 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2008-01-10 | 2008-01-09 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 34,300 | Sold Some | -100 | -0.29 % | $1,653,946 | $1,612,443 | $-41,503 | -2.50 % | $121 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2008-01-10 | 2008-01-09 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 33,200 | Sold Some | -1,100 | -3.20 % | $1,600,904 | $1,560,732 | $-40,172 | -2.50 % | $1,331 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2007-11-15 | 2007-11-14 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 22,600 | Sold Some | -800 | -3.41 % | $986,490 | $1,062,426 | $75,936 | 7.69 % | $-2,688 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2007-11-15 | 2007-11-14 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 34,500 | Added More | 13,000 | 152.94 % | $1,505,925 | $1,621,845 | $115,920 | 7.69 % | $43,680 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2007-11-15 | 2007-11-14 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 33,900 | Sold Some | -600 | -1.73 % | $1,479,735 | $1,593,639 | $113,904 | 7.69 % | $-2,016 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2007-11-15 | 2007-11-14 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 23,400 | Sold Some | -1,000 | -4.09 % | $1,021,410 | $1,100,034 | $78,624 | 7.69 % | $-3,360 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2007-11-15 | 2007-11-14 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 32,200 | Sold Some | -1,700 | -5.01 % | $1,405,530 | $1,513,722 | $108,192 | 7.69 % | $-5,712 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2007-11-15 | 2007-11-14 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 27,633 | Sold Some | -4,567 | -14.18 % | $1,206,180 | $1,299,027 | $92,847 | 7.69 % | $-15,345 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2007-11-15 | 2007-11-14 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 27,600 | Sold Some | -33 | -0.11 % | $1,204,740 | $1,297,476 | $92,736 | 7.69 % | $-111 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2007-11-15 | 2007-11-14 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 26,900 | Sold Some | -700 | -2.53 % | $1,174,185 | $1,264,569 | $90,384 | 7.69 % | $-2,352 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2007-11-15 | 2007-11-14 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 26,600 | Sold Some | -300 | -1.11 % | $1,161,090 | $1,250,466 | $89,376 | 7.69 % | $-1,008 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2007-11-15 | 2007-11-14 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 25,900 | Sold Some | -700 | -2.63 % | $1,130,535 | $1,217,559 | $87,024 | 7.69 % | $-2,352 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2007-11-15 | 2007-11-14 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 24,400 | Sold Some | -1,500 | -5.79 % | $1,065,060 | $1,147,044 | $81,984 | 7.69 % | $-5,040 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2007-11-15 | 2007-11-14 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 21,500 | Sold Some | -1,100 | -4.86 % | $938,475 | $1,010,715 | $72,240 | 7.69 % | $-3,696 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2007-10-26 | 2007-10-25 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 28,000 | Added More | 10,000 | 125.00 % | $1,298,360 | $1,316,280 | $17,920 | 1.38 % | $6,400 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2007-10-26 | 2007-10-25 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 21,500 | Sold Some | -6,500 | -23.21 % | $996,955 | $1,010,715 | $13,760 | 1.38 % | $-4,160 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2007-09-13 | 2007-09-12 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 30,500 | Sold Some | -200 | -0.65 % | $1,174,250 | $1,433,805 | $259,555 | 22.10 % | $-1,702 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2007-09-13 | 2007-09-12 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 18,000 | Sold Some | -120 | -0.66 % | $693,000 | $846,180 | $153,180 | 22.10 % | $-1,021 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2007-09-13 | 2007-09-12 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 18,120 | Sold Some | -100 | -0.54 % | $697,620 | $851,821 | $154,201 | 22.10 % | $-851 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2007-09-13 | 2007-09-12 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 18,220 | Sold Some | -360 | -1.93 % | $701,470 | $856,522 | $155,052 | 22.10 % | $-3,064 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2007-09-13 | 2007-09-12 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 18,580 | Sold Some | -1,580 | -7.83 % | $715,330 | $873,446 | $158,116 | 22.10 % | $-13,446 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2007-09-13 | 2007-09-12 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 20,160 | Sold Some | -1,500 | -6.92 % | $776,160 | $947,722 | $171,562 | 22.10 % | $-12,765 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2007-09-13 | 2007-09-12 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 21,660 | Sold Some | -6,840 | -24.00 % | $833,910 | $1,018,237 | $184,327 | 22.10 % | $-58,208 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2007-09-13 | 2007-09-12 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 28,500 | Sold Some | -2,000 | -6.55 % | $1,097,250 | $1,339,785 | $242,535 | 22.10 % | $-17,020 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2007-09-13 | 2007-09-12 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 30,700 | Sold Some | -300 | -0.96 % | $1,181,950 | $1,443,207 | $261,257 | 22.10 % | $-2,553 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2007-09-13 | 2007-09-12 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 31,000 | Added More | 13,000 | 260.00 % | $1,193,500 | $1,457,310 | $263,810 | 22.10 % | $110,630 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2007-07-12 | 2007-07-11 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 18,000 | Sold Some | -25 | -0.13 % | $718,920 | $846,180 | $127,260 | 17.70 % | $-177 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2007-07-12 | 2007-07-11 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 31,000 | Added More | 13,000 | 260.00 % | $1,238,140 | $1,457,310 | $219,170 | 17.70 % | $91,910 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2007-07-12 | 2007-07-11 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 29,525 | Sold Some | -1,475 | -4.75 % | $1,179,229 | $1,387,970 | $208,742 | 17.70 % | $-10,428 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2007-07-12 | 2007-07-11 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 22,025 | Sold Some | -7,500 | -25.40 % | $879,679 | $1,035,395 | $155,717 | 17.70 % | $-53,025 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2007-07-12 | 2007-07-11 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 21,025 | Sold Some | -1,000 | -4.54 % | $839,739 | $988,385 | $148,647 | 17.70 % | $-7,070 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2007-07-12 | 2007-07-11 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 20,925 | Sold Some | -100 | -0.47 % | $835,745 | $983,684 | $147,940 | 17.70 % | $-707 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2007-07-12 | 2007-07-11 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 20,246 | Sold Some | -679 | -3.24 % | $808,625 | $951,764 | $143,139 | 17.70 % | $-4,801 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2007-07-12 | 2007-07-11 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 20,225 | Sold Some | -21 | -0.10 % | $807,787 | $950,777 | $142,991 | 17.70 % | $-148 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2007-07-12 | 2007-07-11 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 20,125 | Sold Some | -100 | -0.49 % | $803,793 | $946,076 | $142,284 | 17.70 % | $-707 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2007-07-12 | 2007-07-11 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 20,025 | Sold Some | -100 | -0.49 % | $799,799 | $941,375 | $141,577 | 17.70 % | $-707 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2007-07-12 | 2007-07-11 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 19,325 | Sold Some | -700 | -3.49 % | $771,841 | $908,468 | $136,628 | 17.70 % | $-4,949 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2007-07-12 | 2007-07-11 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 18,225 | Sold Some | -1,100 | -5.69 % | $727,907 | $856,757 | $128,851 | 17.70 % | $-7,777 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2007-07-12 | 2007-07-11 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 18,025 | Sold Some | -200 | -1.09 % | $719,919 | $847,355 | $127,437 | 17.70 % | $-1,414 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2007-05-11 | 2007-05-09 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 9,300 | Sold Some | -503 | -5.13 % | $763,902 | $437,193 | $-326,709 | -42.76 % | $17,670 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2007-05-11 | 2007-05-09 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 15,500 | Added More | 6,500 | 260.00 % | $1,273,170 | $728,655 | $-544,515 | -42.76 % | $-228,345 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2007-05-11 | 2007-05-09 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 15,200 | Sold Some | -300 | -1.93 % | $1,248,528 | $714,552 | $-533,976 | -42.76 % | $10,539 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2007-05-11 | 2007-05-09 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 14,300 | Sold Some | -900 | -5.92 % | $1,174,602 | $672,243 | $-502,359 | -42.76 % | $31,617 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2007-05-11 | 2007-05-09 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 12,700 | Sold Some | -1,600 | -11.18 % | $1,043,178 | $597,027 | $-446,151 | -42.76 % | $56,208 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2007-05-11 | 2007-05-09 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 11,800 | Sold Some | -900 | -7.08 % | $969,252 | $554,718 | $-414,534 | -42.76 % | $31,617 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2007-05-11 | 2007-05-09 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 10,600 | Sold Some | -1,200 | -10.16 % | $870,684 | $498,306 | $-372,378 | -42.76 % | $42,156 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2007-05-11 | 2007-05-09 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 10,400 | Sold Some | -200 | -1.88 % | $854,256 | $488,904 | $-365,352 | -42.76 % | $7,026 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2007-05-11 | 2007-05-09 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 10,100 | Sold Some | -300 | -2.88 % | $829,614 | $474,801 | $-354,813 | -42.76 % | $10,539 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2007-05-11 | 2007-05-09 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 9,803 | Sold Some | -297 | -2.94 % | $805,218 | $460,839 | $-344,379 | -42.76 % | $10,434 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2007-05-11 | 2007-05-09 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 9,000 | Sold Some | -300 | -3.22 % | $739,260 | $423,090 | $-316,170 | -42.76 % | $10,539 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2007-05-02 | 2007-05-01 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 12,750 | Added More | 3,750 | 71.42 % | $1,063,478 | $599,378 | $-464,100 | -43.63 % | $-136,500 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2007-05-02 | 2007-05-01 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 9,000 | Sold Some | -3,750 | -29.41 % | $750,690 | $423,090 | $-327,600 | -43.63 % | $136,500 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2007-05-02 | 2007-04-30 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 9,750 | Sold Some | -500 | -4.87 % | $813,248 | $458,348 | $-354,900 | -43.63 % | $18,200 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2007-05-02 | 2007-04-30 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 12,750 | Added More | 3,750 | 71.42 % | $1,063,478 | $599,378 | $-464,100 | -43.63 % | $-136,500 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2007-05-02 | 2007-04-30 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 11,250 | Sold Some | -1,500 | -11.76 % | $938,363 | $528,863 | $-409,500 | -43.63 % | $54,600 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2007-05-02 | 2007-04-30 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 10,250 | Sold Some | -1,000 | -8.88 % | $854,953 | $481,853 | $-373,100 | -43.63 % | $36,400 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2007-05-02 | 2007-04-30 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 9,000 | Sold Some | -750 | -7.69 % | $750,690 | $423,090 | $-327,600 | -43.63 % | $27,300 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2007-03-15 | 2007-03-14 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 9,000 | Sold Some | -200 | -2.17 % | $631,080 | $423,090 | $-207,990 | -32.95 % | $4,622 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2007-03-15 | 2007-03-14 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 15,500 | Added More | 6,500 | 260.00 % | $1,086,860 | $728,655 | $-358,205 | -32.95 % | $-150,215 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2007-03-15 | 2007-03-14 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 13,700 | Sold Some | -1,800 | -11.61 % | $960,644 | $644,037 | $-316,607 | -32.95 % | $41,598 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2007-03-15 | 2007-03-14 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 12,100 | Sold Some | -1,600 | -11.67 % | $848,452 | $568,821 | $-279,631 | -32.95 % | $36,976 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2007-03-15 | 2007-03-14 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 10,700 | Sold Some | -1,400 | -11.57 % | $750,284 | $503,007 | $-247,277 | -32.95 % | $32,354 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2007-03-15 | 2007-03-14 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 10,400 | Sold Some | -300 | -2.80 % | $729,248 | $488,904 | $-240,344 | -32.95 % | $6,933 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2007-03-15 | 2007-03-14 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 10,300 | Sold Some | -100 | -0.96 % | $722,236 | $484,203 | $-238,033 | -32.95 % | $2,311 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2007-03-15 | 2007-03-14 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 9,800 | Sold Some | -500 | -4.85 % | $687,176 | $460,698 | $-226,478 | -32.95 % | $11,555 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2007-03-15 | 2007-03-14 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 9,200 | Sold Some | -600 | -6.12 % | $645,104 | $432,492 | $-212,612 | -32.95 % | $13,866 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2007-01-12 | 2007-01-10 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 12,200 | Sold Some | -3,300 | -21.29 % | $807,152 | $573,522 | $-233,630 | -28.94 % | $63,195 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2007-01-12 | 2007-01-10 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 11,594 | Sold Some | -606 | -4.96 % | $767,059 | $545,034 | $-222,025 | -28.94 % | $11,605 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2007-01-12 | 2007-01-10 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 10,594 | Sold Some | -1,000 | -8.62 % | $700,899 | $498,024 | $-202,875 | -28.94 % | $19,150 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2007-01-12 | 2007-01-10 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 10,494 | Sold Some | -100 | -0.94 % | $694,283 | $493,323 | $-200,960 | -28.94 % | $1,915 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2007-01-12 | 2007-01-10 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 10,100 | Sold Some | -394 | -3.75 % | $668,216 | $474,801 | $-193,415 | -28.94 % | $7,545 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2007-01-12 | 2007-01-10 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 9,000 | Sold Some | -1,100 | -10.89 % | $595,440 | $423,090 | $-172,350 | -28.94 % | $21,065 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2007-01-12 | 2007-01-10 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 15,500 | Added More | 6,500 | 260.00 % | $1,025,480 | $728,655 | $-296,825 | -28.94 % | $-124,475 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2006-11-13 | 2006-11-08 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 11,100 | Sold Some | -200 | -1.76 % | $744,477 | $521,811 | $-222,666 | -29.90 % | $4,012 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2006-11-13 | 2006-11-08 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 9,000 | Sold Some | -1,000 | -10.00 % | $603,630 | $423,090 | $-180,540 | -29.90 % | $20,060 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2006-11-13 | 2006-11-08 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 10,000 | Sold Some | -1,100 | -9.90 % | $670,700 | $470,100 | $-200,600 | -29.90 % | $22,066 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2006-11-13 | 2006-11-08 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 15,500 | Added More | 6,500 | 260.00 % | $1,039,585 | $728,655 | $-310,930 | -29.90 % | $-130,390 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2006-11-13 | 2006-11-08 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 14,300 | Sold Some | -1,200 | -7.74 % | $959,101 | $672,243 | $-286,858 | -29.90 % | $24,072 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2006-11-13 | 2006-11-08 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 12,500 | Sold Some | -1,800 | -12.58 % | $838,375 | $587,625 | $-250,750 | -29.90 % | $36,108 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2006-11-13 | 2006-11-08 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 12,300 | Sold Some | -200 | -1.60 % | $824,961 | $578,223 | $-246,738 | -29.90 % | $4,012 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2006-11-13 | 2006-11-08 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 11,600 | Sold Some | -700 | -5.69 % | $778,012 | $545,316 | $-232,696 | -29.90 % | $14,042 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2006-11-13 | 2006-11-08 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 11,300 | Sold Some | -300 | -2.58 % | $757,891 | $531,213 | $-226,678 | -29.90 % | $6,018 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2006-09-15 | 2006-09-13 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 9,990 | Sold Some | -2,100 | -17.36 % | $646,853 | $469,630 | $-177,223 | -27.39 % | $37,254 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2006-09-15 | 2006-09-13 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 15,500 | Added More | 6,500 | 260.00 % | $1,003,625 | $728,655 | $-274,970 | -27.39 % | $-115,310 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2006-09-15 | 2006-09-13 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 14,490 | Sold Some | -1,010 | -6.51 % | $938,228 | $681,175 | $-257,053 | -27.39 % | $17,917 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2006-09-15 | 2006-09-13 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 14,476 | Sold Some | -14 | -0.09 % | $937,321 | $680,517 | $-256,804 | -27.39 % | $248 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2006-09-15 | 2006-09-13 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 13,290 | Sold Some | -1,186 | -8.19 % | $860,528 | $624,763 | $-235,765 | -27.39 % | $21,040 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2006-09-15 | 2006-09-13 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 12,990 | Sold Some | -300 | -2.25 % | $841,103 | $610,660 | $-230,443 | -27.39 % | $5,322 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2006-09-15 | 2006-09-13 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 12,799 | Sold Some | -191 | -1.47 % | $828,735 | $601,681 | $-227,054 | -27.39 % | $3,388 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2006-09-15 | 2006-09-13 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 12,090 | Sold Some | -709 | -5.53 % | $782,828 | $568,351 | $-214,477 | -27.39 % | $12,578 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2006-09-15 | 2006-09-13 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 9,000 | Sold Some | -990 | -9.90 % | $582,750 | $423,090 | $-159,660 | -27.39 % | $17,563 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2006-07-14 | 2006-07-12 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 11,200 | Sold Some | -100 | -0.88 % | $670,992 | $526,512 | $-144,480 | -21.53 % | $1,290 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2006-07-14 | 2006-07-12 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 15,500 | Added More | 6,500 | 260.00 % | $928,605 | $728,655 | $-199,950 | -21.53 % | $-83,850 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2006-07-14 | 2006-07-12 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 15,450 | Sold Some | -50 | -0.32 % | $925,610 | $726,305 | $-199,305 | -21.53 % | $645 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2006-07-14 | 2006-07-12 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 15,400 | Sold Some | -50 | -0.32 % | $922,614 | $723,954 | $-198,660 | -21.53 % | $645 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2006-07-14 | 2006-07-12 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 15,300 | Sold Some | -100 | -0.64 % | $916,623 | $719,253 | $-197,370 | -21.53 % | $1,290 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2006-07-14 | 2006-07-12 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 15,200 | Sold Some | -100 | -0.65 % | $910,632 | $714,552 | $-196,080 | -21.53 % | $1,290 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2006-07-14 | 2006-07-12 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 14,900 | Sold Some | -300 | -1.97 % | $892,659 | $700,449 | $-192,210 | -21.53 % | $3,870 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2006-07-14 | 2006-07-12 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 14,600 | Sold Some | -300 | -2.01 % | $874,686 | $686,346 | $-188,340 | -21.53 % | $3,870 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2006-07-14 | 2006-07-12 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 14,500 | Sold Some | -100 | -0.68 % | $868,695 | $681,645 | $-187,050 | -21.53 % | $1,290 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2006-07-14 | 2006-07-12 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 14,300 | Sold Some | -200 | -1.37 % | $856,713 | $672,243 | $-184,470 | -21.53 % | $2,580 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2006-07-14 | 2006-07-12 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 14,200 | Sold Some | -100 | -0.69 % | $850,722 | $667,542 | $-183,180 | -21.53 % | $1,290 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2006-07-14 | 2006-07-12 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 13,900 | Sold Some | -300 | -2.11 % | $832,749 | $653,439 | $-179,310 | -21.53 % | $3,870 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2006-07-14 | 2006-07-12 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 13,800 | Sold Some | -100 | -0.71 % | $826,758 | $648,738 | $-178,020 | -21.53 % | $1,290 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2006-07-14 | 2006-07-12 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 13,500 | Sold Some | -300 | -2.17 % | $808,785 | $634,635 | $-174,150 | -21.53 % | $3,870 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2006-07-14 | 2006-07-12 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 13,300 | Sold Some | -200 | -1.48 % | $796,803 | $625,233 | $-171,570 | -21.53 % | $2,580 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2006-07-14 | 2006-07-12 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 13,200 | Sold Some | -100 | -0.75 % | $790,812 | $620,532 | $-170,280 | -21.53 % | $1,290 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2006-07-14 | 2006-07-12 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 13,100 | Sold Some | -100 | -0.75 % | $784,821 | $615,831 | $-168,990 | -21.53 % | $1,290 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2006-07-14 | 2006-07-12 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 12,800 | Sold Some | -300 | -2.29 % | $766,848 | $601,728 | $-165,120 | -21.53 % | $3,870 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2006-07-14 | 2006-07-12 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 12,600 | Sold Some | -200 | -1.56 % | $754,866 | $592,326 | $-162,540 | -21.53 % | $2,580 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2006-07-14 | 2006-07-12 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 12,400 | Sold Some | -200 | -1.58 % | $742,884 | $582,924 | $-159,960 | -21.53 % | $2,580 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2006-07-14 | 2006-07-12 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 12,000 | Sold Some | -400 | -3.22 % | $718,920 | $564,120 | $-154,800 | -21.53 % | $5,160 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2006-07-14 | 2006-07-12 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 11,800 | Sold Some | -200 | -1.66 % | $706,938 | $554,718 | $-152,220 | -21.53 % | $2,580 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2006-07-14 | 2006-07-12 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 11,700 | Sold Some | -100 | -0.84 % | $700,947 | $550,017 | $-150,930 | -21.53 % | $1,290 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2006-07-14 | 2006-07-12 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 11,600 | Sold Some | -100 | -0.85 % | $694,956 | $545,316 | $-149,640 | -21.53 % | $1,290 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2006-07-14 | 2006-07-12 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 11,400 | Sold Some | -200 | -1.72 % | $682,974 | $535,914 | $-147,060 | -21.53 % | $2,580 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2006-07-14 | 2006-07-12 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 11,300 | Sold Some | -100 | -0.87 % | $676,983 | $531,213 | $-145,770 | -21.53 % | $1,290 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2006-07-14 | 2006-07-12 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 11,000 | Sold Some | -200 | -1.78 % | $659,010 | $517,110 | $-141,900 | -21.53 % | $2,580 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2006-07-14 | 2006-07-12 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 10,700 | Sold Some | -300 | -2.72 % | $641,037 | $503,007 | $-138,030 | -21.53 % | $3,870 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2006-07-14 | 2006-07-12 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 10,500 | Sold Some | -200 | -1.86 % | $629,055 | $493,605 | $-135,450 | -21.53 % | $2,580 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2006-07-14 | 2006-07-12 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 10,400 | Sold Some | -100 | -0.95 % | $623,064 | $488,904 | $-134,160 | -21.53 % | $1,290 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2006-07-14 | 2006-07-12 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 10,300 | Sold Some | -100 | -0.96 % | $617,073 | $484,203 | $-132,870 | -21.53 % | $1,290 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2006-07-14 | 2006-07-12 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 10,200 | Sold Some | -100 | -0.97 % | $611,082 | $479,502 | $-131,580 | -21.53 % | $1,290 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2006-07-14 | 2006-07-12 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 10,100 | Sold Some | -100 | -0.98 % | $605,091 | $474,801 | $-130,290 | -21.53 % | $1,290 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2006-07-14 | 2006-07-12 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 10,000 | Sold Some | -100 | -0.99 % | $599,100 | $470,100 | $-129,000 | -21.53 % | $1,290 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2006-07-14 | 2006-07-12 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 9,900 | Sold Some | -100 | -1.00 % | $593,109 | $465,399 | $-127,710 | -21.53 % | $1,290 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2006-07-14 | 2006-07-12 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 9,700 | Sold Some | -200 | -2.02 % | $581,127 | $455,997 | $-125,130 | -21.53 % | $2,580 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2006-07-14 | 2006-07-12 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 9,600 | Sold Some | -100 | -1.03 % | $575,136 | $451,296 | $-123,840 | -21.53 % | $1,290 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2006-07-14 | 2006-07-12 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 9,500 | Sold Some | -100 | -1.04 % | $569,145 | $446,595 | $-122,550 | -21.53 % | $1,290 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2006-07-14 | 2006-07-12 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 9,400 | Sold Some | -100 | -1.05 % | $563,154 | $441,894 | $-121,260 | -21.53 % | $1,290 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2006-07-14 | 2006-07-12 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 9,300 | Sold Some | -100 | -1.06 % | $557,163 | $437,193 | $-119,970 | -21.53 % | $1,290 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2006-07-14 | 2006-07-12 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 9,200 | Sold Some | -100 | -1.07 % | $551,172 | $432,492 | $-118,680 | -21.53 % | $1,290 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2006-07-14 | 2006-07-12 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 9,000 | Sold Some | -200 | -2.17 % | $539,190 | $423,090 | $-116,100 | -21.53 % | $2,580 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2006-05-11 | 2006-05-10 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 11,060 | Sold Some | -2,040 | -15.57 % | $625,996 | $519,931 | $-106,065 | -16.94 % | $19,564 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2006-05-11 | 2006-05-10 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 10,200 | Sold Some | -860 | -7.77 % | $577,320 | $479,502 | $-97,818 | -16.94 % | $8,247 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2006-05-11 | 2006-05-10 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 9,000 | Sold Some | -1,200 | -11.76 % | $509,400 | $423,090 | $-86,310 | -16.94 % | $11,508 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2006-05-11 | 2006-05-10 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 15,500 | Added More | 6,500 | 260.00 % | $877,300 | $728,655 | $-148,645 | -16.94 % | $-62,335 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2006-05-11 | 2006-05-10 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 13,100 | Sold Some | -2,400 | -15.48 % | $741,460 | $615,831 | $-125,629 | -16.94 % | $23,016 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2006-03-10 | 2006-03-08 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 12,700 | Sold Some | -600 | -4.51 % | $775,843 | $597,027 | $-178,816 | -23.04 % | $8,448 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2006-03-10 | 2006-03-08 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 11,300 | Sold Some | -1,400 | -11.02 % | $690,317 | $531,213 | $-159,104 | -23.04 % | $19,712 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2006-03-10 | 2006-03-08 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 10,100 | Sold Some | -1,200 | -10.61 % | $617,009 | $474,801 | $-142,208 | -23.04 % | $16,896 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2006-03-10 | 2006-03-08 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 9,000 | Sold Some | -1,100 | -10.89 % | $549,810 | $423,090 | $-126,720 | -23.04 % | $15,488 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2006-03-10 | 2006-03-08 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 15,500 | Added More | 6,500 | 260.00 % | $946,895 | $728,655 | $-218,240 | -23.04 % | $-91,520 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2006-03-10 | 2006-03-08 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 14,300 | Sold Some | -1,200 | -7.74 % | $873,587 | $672,243 | $-201,344 | -23.04 % | $16,896 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2006-03-10 | 2006-03-08 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 13,400 | Sold Some | -900 | -6.29 % | $818,606 | $629,934 | $-188,672 | -23.04 % | $12,672 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2006-03-10 | 2006-03-08 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 13,300 | Sold Some | -100 | -0.74 % | $812,497 | $625,233 | $-187,264 | -23.04 % | $1,408 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2005-11-23 | 2005-11-22 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 9,000 | Sold Some | -6,000 | -40.00 % | $484,110 | $423,090 | $-61,020 | -12.60 % | $40,680 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2005-05-17 | 2005-05-16 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 16,200 | Sold Some | -11,800 | -42.14 % | $630,180 | $761,562 | $131,382 | 20.84 % | $-95,698 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2005-05-17 | 2005-05-16 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 28,000 | Added More | 20,000 | -166.66 % | $1,089,200 | $1,316,280 | $227,080 | 20.84 % | $162,200 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2005-05-17 | 2005-05-16 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 15,000 | Sold Some | -1,200 | -7.40 % | $583,500 | $705,150 | $121,650 | 20.84 % | $-9,732 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2004-12-10 | 2004-12-08 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 16,000 | Added More | 8,000 | - % | $582,080 | $752,160 | $170,080 | 29.21 % | $85,040 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2004-12-10 | 2004-12-08 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 8,000 | No Compare | -8,000 | -50.00 % | $291,040 | $376,080 | $85,040 | 29.21 % | $-85,040 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2004-11-12 | 2004-11-10 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 16,000 | Added More | 8,000 | - % | $591,040 | $752,160 | $161,120 | 27.26 % | $80,560 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2004-11-12 | 2004-11-10 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 8,000 | No Compare | -8,000 | -50.00 % | $295,520 | $376,080 | $80,560 | 27.26 % | $-80,560 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2004-10-13 | 2004-10-13 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 16,000 | Added More | 8,000 | - % | $600,800 | $752,160 | $151,360 | 25.19 % | $75,680 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2004-10-13 | 2004-10-13 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 8,000 | No Compare | -8,000 | -50.00 % | $300,400 | $376,080 | $75,680 | 25.19 % | $-75,680 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2004-09-09 | 2004-09-08 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 8,000 | No Compare | -8,000 | -50.00 % | $278,800 | $376,080 | $97,280 | 34.89 % | $-97,280 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2004-09-09 | 2004-09-08 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 16,000 | Added More | 8,000 | - % | $557,600 | $752,160 | $194,560 | 34.89 % | $97,280 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2004-08-13 | 2004-08-11 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 8,000 | Added More | 4,000 | - % | $503,920 | $376,080 | $-127,840 | -25.36 % | $-63,920 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2004-08-13 | 2004-08-11 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 4,000 | No Compare | -4,000 | -50.00 % | $251,960 | $188,040 | $-63,920 | -25.36 % | $63,920 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2004-07-14 | 2004-07-14 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 4,000 | No Compare | -4,000 | -50.00 % | $257,240 | $188,040 | $-69,200 | -26.90 % | $69,200 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2004-07-14 | 2004-07-14 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 8,000 | Added More | 4,000 | - % | $514,480 | $376,080 | $-138,400 | -26.90 % | $-69,200 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2004-06-09 | 2004-06-09 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 8,000 | Added More | 4,000 | - % | $503,760 | $376,080 | $-127,680 | -25.34 % | $-63,840 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2004-06-09 | 2004-06-09 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 4,000 | No Compare | -4,000 | -50.00 % | $251,880 | $188,040 | $-63,840 | -25.34 % | $63,840 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2004-05-13 | 2004-05-12 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 8,000 | Added More | 4,000 | - % | $453,280 | $376,080 | $-77,200 | -17.03 % | $-38,600 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2004-05-13 | 2004-05-12 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 4,000 | No Compare | -4,000 | -50.00 % | $226,640 | $188,040 | $-38,600 | -17.03 % | $38,600 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2004-02-13 | 2004-02-12 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 4,000 | Added More | 2,000 | - % | $233,200 | $188,040 | $-45,160 | -19.36 % | $-22,580 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2004-02-10 | 2004-02-09 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 4,900 | Sold Some | -100 | -2.00 % | $281,113 | $230,349 | $-50,764 | -18.05 % | $1,036 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2004-02-10 | 2004-02-09 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 2,000 | Sold Some | -2,700 | -57.44 % | $114,740 | $94,020 | $-20,720 | -18.05 % | $27,972 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2004-02-10 | 2004-02-09 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 10,000 | Added More | 8,000 | -133.33 % | $573,700 | $470,100 | $-103,600 | -18.05 % | $-82,880 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2004-02-10 | 2004-02-09 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 5,400 | Sold Some | -4,600 | -46.00 % | $309,798 | $253,854 | $-55,944 | -18.05 % | $47,656 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2004-02-10 | 2004-02-09 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 5,000 | Sold Some | -400 | -7.40 % | $286,850 | $235,050 | $-51,800 | -18.05 % | $4,144 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |
| 2004-02-10 | 2004-02-09 | 4 | Gilead Sciences Inc | GILD | US | Therapeutics | 4,700 | Sold Some | -200 | -4.08 % | $269,639 | $220,947 | $-48,692 | -18.05 % | $2,072 | X | | | | | History of Berg Paul Ownership Of Gilead Sciences Inc |